Xenon Pharmaceuticals Inc. | Ownership
Companies that own Xenon Pharmaceuticals Inc.
venBio Select Advisor LLC
1,202,118
6.24%
1,202,118
0.54%
06/30/2018
Adage Capital Management LP
800,000
4.15%
800,000
0.02%
06/30/2018
BVF Partners LP
720,830
3.74%
0
0.64%
06/30/2018
OrbiMed Advisors LLC
634,812
3.3%
0
0.09%
06/30/2018
Capital Research & Management Co. (World Investors)
579,500
3.01%
-849,500
0%
07/31/2018
Renaissance Technologies LLC
489,500
2.54%
201,500
0.01%
06/30/2018
Granite Point Capital Management LP
482,200
2.5%
482,200
2.57%
06/30/2018
Schonfeld Strategic Advisors LLC
455,000
2.36%
70,000
0.31%
06/30/2018
Acuta Capital Partners LLC
450,000
2.34%
450,000
1.04%
06/30/2018
Sphera Funds Management Ltd.
439,034
2.27%
439,034
0.84%
06/30/2018
| Address |
3650 Gilmore Way
Burnaby British Columbia V5G 4W8
Canada
|
|
Employees
|
- |
| Website |
http://www.xenon-pharma.com |
| Updated |
07/08/2019 |
| Xenon Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in discovering and developing a pipeline of differentiated therapeutics. It has built a core enabling discovery platform for the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies. |
